Clin2
NCT06781372Possibly a fitNot yet recruiting

Testing tumor cells for drug response in glioblastoma

GlioblastomaGlioblastoma Multiforme (GBM)Glioblastoma Multiforme, Adult

Part of Cancer clinical trials.

This study tests your tumor cells in the lab to see which drugs might work best for your specific cancer. By doing this, doctors hope to find more effective treatments for glioblastoma.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are having surgery to remove the brain tumor (not just a small biopsy).
  • Your tumor is confirmed as glioblastoma, a type of brain cancer.
  • You have not had chemotherapy or radiation before this surgery.
  • You can understand and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06512311Recruiting
Personalized drug testing for newly diagnosed glioblastoma

This trial tests whether testing drugs on your tumor cells in a lab can help find the best treatment for you. It is for people with a specific type of glioblastoma that has not been treated yet.

Vienna, State of Vienna
NCT06782984Recruiting
Testing drugs on your glioblastoma tumor model

This trial uses a lab-grown model of your tumor (called an organoid) to test whether different drugs might work against it. The goal is to find the best treatment for your specific glioblastoma.

Daejeon, Chungcheongnam-do
NCT06804655Recruiting· Phase 2
Personalized drug testing for stubborn brain tumors

This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.

Basel, Basel-Landschaft
NCT06113705Recruiting
Better MRI and blood tests for glioblastoma treatment response

This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.

Rozzano
NCT03970447Recruiting· Phase 2/Phase 3
Testing several treatment options for new or returning glioblastoma

This trial studies different treatment regimens for people with glioblastoma that is either newly diagnosed or has come back. It aims to find which treatment approach works best for controlling the tumor and improving outcomes.

Birmingham, Alabama
NCT07218367Not yet recruiting· Phase 1
Study of new imaging before brain surgery for glioblastoma

This trial looks at a new imaging method to help doctors see brain tumors more clearly before surgery. It may help remove the tumor more safely and completely.

West Los Angeles, California

Hear when a new Glioblastoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.